Evidence map›Paper›PMID 39404697›Full record

ArticleNeuroprotection (Chichester, England)2024

Tolerability and first hints for potential efficacy of motor-cognitive training under inspiratory hypoxia in health and neuropsychiatric disorders: A translational viewpoint.

Svea-Solveig Mennen, Maren Franta, Martin Begemann, Justus B H Wilke, Roman Schröder, Umer Javed Butt, Jonathan-Alexis Cortés-Silva, Umut Çakır, Marie Güra, Markus de Marées and 14 more

Erratum issuedAbstract read
In one paragraph

Article in Neuroprotection (Chichester, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Hypoxia in multiple sclerosis.Redox biology · 2025
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Svea-Solveig Mennen *Clinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.
Maren Franta *Clinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.
Martin BegemannClinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.
Justus B H WilkeClinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.
Roman SchröderClinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.
Umer Javed ButtClinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.
Jonathan-Alexis Cortés-SilvaClinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.
Umut ÇakırClinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.
Marie GüraClinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.
Markus de MaréesDepartment of Sports Medicine, Ruhr University, Bochum, Germany.
Vinicius Daguano GastaldiClinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.
Johannes BurtscherInstitute of Sports Science, University of Lausanne, Lausanne, Switzerland.
Julie SchanzDepartment of Clinical Chemistry and Interdisciplinary UMG Laboratory, University Medical Center Göttingen, Göttingen, Germany.
Matthias BohnClinical Pharmacy, Georg-August-University, Göttingen, Germany.
Martin BurtscherFaculty of Sports Science, University of Innsbruck, Innsbruck, Austria.
Andreas FischerDepartment of Clinical Chemistry and Interdisciplinary UMG Laboratory, University Medical Center Göttingen, Göttingen, Germany.
Luise PoustkaDepartment of Child and Adolescent Psychiatry & Psychotherapy, Center for Psychosocial Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Peter HammermannHBL Investmentpartners GmbH, München-Frankfurt, Germany.
Markus StadlerDatico Sport & Health GmbH, Burghausen, Germany.
Fred LühderInstitute for Neuroimmunology and Multiple Sclerosis Research, University Medical Center Göttingen, Göttingen, Germany.
Manvendra SinghClinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.
Klaus-Armin NaveDepartment of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.
Kamilla Woznica MiskowiakFrederiksberg Hospital and Department of Psychology, Neurocognition and Emotion in Affective Disorders (NEAD) Centre, Copenhagen Affective Disorder Research Centre, Psychiatric Centre Copenhagen, University of Copenhagen, Copenhagen, Denmark.
Hannelore EhrenreichClinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypoxia is more and more perceived as pivotal physiological driving force, allowing cells in the brain and elsewhere to acclimate to lowered oxygen (O

Indexed as

braincognitionerythropoietinfunctional hypoxiahigh-parameter flow cytometryimmune cellsoxygen saturationphysical fitnessplasticity

Identifiers

PMID39404697
PMCPMC7616549

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.